Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature

Int J Dermatol. 2013 May;52(5):643-4. doi: 10.1111/j.1365-4632.2011.04921.x. Epub 2012 Oct 9.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Black People
  • Drug Eruptions / etiology*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Hyperpigmentation / chemically induced*
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Male
  • Polyethylene Glycols / adverse effects*
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use
  • Tongue / pathology*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a